Publication | Open Access
miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1
54
Citations
20
References
2018
Year
miR-29b recedes the progression of MM via downregulating FOXP1, which may provide a potential biological target for MM treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1